EBAC

European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC

Delisted

EBAC was delisted on the 2nd of March, 2023.

Back to rankings

45 hedge funds and large institutions have $69.6M invested in European Biotech Acquisition Corp. Class A Ordinary Shares in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

Holders
45
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$8K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$7.49M
2
+$4.5M
3
+$1.6M
4
AMH
Apollo Management Holdings
New York
+$967K
5
Marshall Wace
Marshall Wace
United Kingdom
+$852K

Top Sellers

1
-$1.43M
2
-$87.3K
3
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$7.49M
2
$6.07M
3
$4.91M
4
$4.88M
5
$4.83M
6
$4.01M
7
$3.82M
8
$2.92M
9
$2.91M
10
$2.67M
11
$2.42M
12
$1.94M
13
$1.94M
14
$1.45M
15
$1.45M
16
$1.21M
17
$1.21M
18
$1.21M
19
$1.17M
20
$971K
21
$970K
22
$969K
23
$969K
24
$967K
25
$937K
1
2